I am a PhD trained statistician with demonstrated experience in translational science, specifically, in the development biomarkers used to inform healthcare decisions. I have over 30 years of experience in leading quantitative cores as part of large extramurally funded NIH and NCI grants. I am currently the Core Director of the Data Sciences Core on the Precision Aging Network as well Co-Lead for the data integration project, Project 4; and Director of the Data Sciences Core (Core B) of a NIA sponsored PPG on Thymic Peripheral Aspects of T Cell Aging and Rejuvenation (P01 AG052359). I was a Co-Investigator on the Skin P01 at the University of Arizona Cancer Center for four years. Formerly, I was the Co-Director of the Statistics, Data Management, and Bioinformatics Core to build infrastructure for a program to study health disparities (P20 MD000516) a Meharry Medical Center and Vanderbilt University collaboration. During this time was the Director of the Biostatistics Core for a co-operative agreement to evaluate control measures for infectious diseases other than AIDS (N01 AI25462). Also, I was the lead of the Biostatistics Core of the SPORE in GI Cancer (P50 CA95103) at Vanderbilt University and the Director of the Biomarker Discovery and Statistics Core of SPORE in GI Cancer at the University of Arizona (P50 CA95060)as well as Co-Lead for Project 1, a study to examine polyamine biomarkers obtained after treatment with the chemo preventative agents DFMO/sulindac. The University of Arizona project of the GI SPORE led to an approved patent and was antecedent of the pharmaceutical company, Cancer Prevention Pharmaceuticals, Inc., Tucson, AZ.